These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34703296)

  • 21. Evaluation of simple and cost-effective immuno- haematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus - A retrospective study in Andhra Pradesh, India.
    Ramesh J; Reddy SLS; Rajesh M; Varghese J
    Diabetes Metab Syndr; 2021; 15(3):739-745. PubMed ID: 33819728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation Between IL-8, C-Reactive Proteins (CRP) and Neutrophil to Lymphocyte Ratio (NLR) as Predictor of Mortality in COVID-19 Patients with Diabetes Mellitus Comorbidity.
    Iskandar A; Mayashinta DK; Robert R; Samsu N; Endharti AT; Widjajanto E
    Int J Gen Med; 2023; 16():2349-2354. PubMed ID: 37313045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Could Some Laboratory Parameters Predict Mortality in COVID-19?
    Nurlu N; Ozturk OO; Cat A; Altunok ES; Gumus A
    Clin Lab; 2021 Aug; 67(8):. PubMed ID: 34383425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of Neutrophil-Lymphocyte Ratio (NLR) as an Indicator of Disease Severity and Prognostic Marker among Patients with Covid-19 Infection in a Tertiary Care Centre in Bangalore - A Retrospective Study.
    PrakashRao VV
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comorbidities influence the predictive power of hematological markers for mortality in hospitalized COVID-19 patients.
    Parthasarathi A; Basavaraja CK; Arunachala S; Chandran S; Venkataraman H; Satheesh A; Mahesh PA
    Adv Respir Med; 2022 Jan; ():. PubMed ID: 35099049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients.
    Anurag A; Jha PK; Kumar A
    Diabetes Metab Syndr; 2020; 14(6):2099-2102. PubMed ID: 33160224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in evaluation of inflammation in non-dialysis patients with end-stage renal disease (ESRD).
    Li P; Xia C; Liu P; Peng Z; Huang H; Wu J; He Z
    BMC Nephrol; 2020 Nov; 21(1):511. PubMed ID: 33238906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Hematologic biomarkers and their combinations with disease severity and mortality in COVID-19- an Indian perspective.
    Pujani M; Raychaudhuri S; Verma N; Kaur H; Agarwal S; Singh M; Jain M; Chandoke RK; Singh K; Sidam D; Chauhan V; Singh A; Katarya K
    Am J Blood Res; 2021; 11(2):180-190. PubMed ID: 34079633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.
    Jimeno S; Ventura PS; Castellano JM; García-Adasme SI; Miranda M; Touza P; Lllana I; López-Escobar A
    Eur J Clin Invest; 2021 Jan; 51(1):e13404. PubMed ID: 32918295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.
    Abdelhady SA; Rageh F; Ahmed SS; Al-Touny SA; Riad E; Elhoseeny MM; Khalifa AA; Salim A; Farghly MI; Elgamal R
    Egypt J Immunol; 2022 Apr; 29(2):57-67. PubMed ID: 35436055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematological Parameters as Diagnostic Factors: Correlation with Severity of COVID-19.
    Dadkhah M; Matin S; Safarzadeh E; Rezaei N; Negaresh M; Salehzadeh H; Matin S; Sharifiazar A; Abazari M
    Acta Biomed; 2022 May; 93(2):e2022061. PubMed ID: 35546008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of neutrophil-to-lymphocyte ratio in the classification diagnosis of coronavirus disease 2019].
    Fei M; Tong F; Tao X; Wang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):554-558. PubMed ID: 32576346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between generalized epileptic seizure and neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and neutrophil mediated inflammation.
    Güneş M; Büyükgöl H
    Int J Neurosci; 2020 Nov; 130(11):1095-1100. PubMed ID: 31983256
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of hematological and inflammatory parameters associated with disease severity in hospitalized patients of COVID-19.
    Sana A; Avneesh M
    J Family Med Prim Care; 2022 Jan; 11(1):260-264. PubMed ID: 35309629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic Profile of Prognostic Hematologic Indicators in Patient Under Intensive Care for COVID-19 Disease: A One-Year Study at a Tertiary Care Centre in South India.
    Balasubramanian J; Suman FR; Stephen IR; Shanmugam SG; Mani R; Mathan B; P L
    Cureus; 2021 Nov; 13(11):e19585. PubMed ID: 34926056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality in ICU COVID-19 Patients Is Associated with Neutrophil-to-Lymphocyte Ratio (NLR): Utility of NLR as a Promising Immunohematological Marker.
    Seyfi S; Azadmehr A; Ezoji K; Nabipour M; Babazadeh A; Saleki K; Mahmoodi M; Pouladi AH
    Interdiscip Perspect Infect Dis; 2023; 2023():9048749. PubMed ID: 38025794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of biomarkers in prognostication of moderate and severe COVID-19 cases.
    Pal S; Sengupta S; Lahiri S; Ghosh A; Bhowmick K
    J Family Med Prim Care; 2023 Dec; 12(12):3186-3193. PubMed ID: 38361890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
    Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
    Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil-to-Lymphocyte Ratio, derived Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio as risk factors in critically ill COVID-19 patients, a single centered study.
    Noor A; Akhtar F; Tashfeen S; Anwar N; Saleem B; Khan SA; Akram Z; Shahid S
    J Ayub Med Coll Abbottabad; 2020; 32(Suppl 1)(4):S595-S601. PubMed ID: 33754514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis.
    Khalid A; Ali Jaffar M; Khan T; Abbas Lail R; Ali S; Aktas G; Waris A; Javaid A; Ijaz N; Muhammad N
    Hematology; 2021 Dec; 26(1):529-542. PubMed ID: 34334100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.